Home
Home

degludec

Degludec And Liraglutide: 2 Drivers Of Novo Nordisk's Growth

Degludec And Liraglutide: 2 Drivers Of Novo Nordisk's Growth
Seeking Alpha

Novo Aims for Tresiba U.S. Approval in First Half of 2013

Novo Aims for Tresiba U.S. Approval in First Half of 2013
Bloomberg

FDA panel recommends approval of Novo degludec insulin

FDA panel recommends approval of Novo degludec insulin
Reuters

FDA staff highlight heart risk with Novo insulin

FDA staff highlight heart risk with Novo insulin
Reuters

Novo Nordisk says FDA disclosed focus of upcoming panel meeting

Novo Nordisk says FDA disclosed focus of upcoming panel meeting
The Fly on the Wall

FDA panel to weigh heart safety of Novo's new insulin

FDA panel to weigh heart safety of Novo's new insulin
Reuters

Novo's long-acting insulin degludec takes big step to megamarket status

Novo's long-acting insulin degludec takes big step to megamarket status
Fierce Biotech

Novo faces new hurdle in long-acting insulin race

Novo faces new hurdle in long-acting insulin race
Reuters

Sanofi, Novo Nordisk, Amylin all tout diabetes treatments at ADA

Sanofi, Novo Nordisk, Amylin all tout diabetes treatments at ADA
Fierce Pharma

FDA extends review of Novo Nordisk's Degludec by 3 mths

FDA extends review of Novo Nordisk's Degludec by 3 mths
Reuters